Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations
E.M.E. Coerver(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Zoé L. E. van Kempen(Amsterdam Neuroscience), Arman Eshaghi(Queen Mary University of London), Maria Pia Sormani(University of Genoa), Frederik Barkhof(Netherlands Institute for Neuroscience), Douglas L. Arnold(University of Oxford), Olga Ciccarelli(Queen Mary University of London), Menno M. Schoonheim(Amsterdam Neuroscience), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Sezgi Kaçar(Amsterdam Neuroscience), Jop Mostert(Rijnstate Hospital), Marcus W Koch(University of Calgary)
Cited by 13
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
|NeuroImage|2006|6.6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k